Successful treatment of idiopathic angioedema with ecallantide

Journal of Allergy and Clinical Immunology: In Practice

Volumn 1, Issue 3, 2013, Pages 297-298

  Berry, Alalia ^a   Firszt, Rafael ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CETIRIZINE; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; CORTICOSTEROID; DANAZOL; DIPHENHYDRAMINE; ECALLANTIDE; FEXOFENADINE; HYDROXYZINE; IMMUNOGLOBULIN E; MEDROXYPROGESTERONE ACETATE; TRYPTASE;

ABDOMINAL PAIN; ADOLESCENT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DIARRHEA; DISEASE DURATION; EYELID EDEMA; FACE EDEMA; FEMALE; HUMAN; SKIN TEST; TONGUE EDEMA; TREATMENT OUTCOME;

ABDOMINAL PAIN; ADOLESCENT; ANGIOEDEMA; BRADYKININ; COMPLEMENT C1 INHIBITOR PROTEIN; FACE; FEMALE; HUMANS; PEPTIDES; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877086721     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.03.007     Document Type: Article

References (10)

1. Bas M., Hoffman T.K., Kojada G. Evaluation and management of angioedema of the head and neck. Curr Opinion Otolaryngol Head Neck Surg 2006, 14:170-175.
2. Bas M., Adams V., Suvorava T., Niehues T., Hoffman T.K., Kojada G. Nonallergic angioedema: role of bradykinin. Allergy 2007, 62:842-856.
3. Firszt R., Frank M.M. An overview of novel therapies for acute hereditary angioedema. Am J Clin Dermatol 2010, 11:383-388.
4. Agostoni A., Aygören-Pürsün E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004, 114:S51-131.
5. Schneider L., Lumry W., Vegh A., Williams A.H., Schmalbach T. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. J Allergy Clin Immunol 2007, 120:416-422.
6. Kalbitor (ecallantide): US prescribing information [online]. Available from:. Accessed December 15, 2012. http://www.kalbitor.com/pdf/KalbitorFullPrescribingInformation.pdf.
7. Cicardi M., Levy R.J., McNeil D.L., Li H.H., Sheffer A.L., Campion M., et al. Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 2010, 363:523-531.
8. Levy R.J., Lumry W.R., McNeil D.L., Li H.H., Campion M., Horn P.T., Pullman W.E. EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. Ann Allergy Asthma Immunol 2010, 104:523-529.
9. Cronin J.A., Maples K.M. Treatment of an acute attack of type III hereditary angioedema with ecallantide. Ann Allergy Asthma Immunol 2012, 108:61-62.
10. McNeil DL. Clinical experience with ecallantide in idiopathic angioedema. Presented in poster form at American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting, November 2012, Anaheim, Calif.